No, arterial and venous CO₂ do not have the same reference ranges
Arterial CO₂ (PaCO₂) and venous CO₂ (PvCO₂) have distinctly different values and cannot be used interchangeably for clinical monitoring. The venous-arterial PCO₂ gradient averages approximately 4-6 mmHg, with venous values consistently higher than arterial values 1, 2, 3.
Key Physiologic Differences
Normal arterial PCO₂ ranges from 35-45 mmHg, while venous PCO₂ is typically 4-6 mmHg higher due to tissue CO₂ production and venous return 1, 2. This gradient reflects normal cellular metabolism and is not a measurement error.
Specific Gradient Data:
- Mean venous-arterial difference: +5.8 mmHg (SD 4.6 mmHg) in critically ill patients 2
- Pooled mean difference: +4.41 mmHg (95% CI 2.55-6.27) across multiple studies 3
- 95% limits of agreement: -20.4 to +25.8 mmHg, indicating substantial variability 3
- In elderly patients specifically, mean bias is +10.0 mmHg with extremely wide limits of agreement (2.7 to -22.8 mmHg) 1
Clinical Implications for Monitoring
When Venous CO₂ Can Be Used:
A normal peripheral venous PCO₂ has good negative predictive value for excluding hypercapnic respiratory disease 3. If venous PCO₂ is normal, arterial PCO₂ is likely normal, making it useful as a screening tool.
When Arterial CO₂ Is Required:
- All critically ill patients 4
- Patients with shock or hypotension (systolic BP <90 mmHg) 4
- Suspected hypercapnic respiratory failure 5, 4
- Acute respiratory acidosis requiring precise ventilatory management 6
- When absolute PCO₂ values guide treatment decisions (e.g., NIV titration, mechanical ventilation) 7
Surrogate Monitoring Methods
End-Tidal CO₂ (PETCO₂):
- Cannot reliably substitute for arterial PCO₂, especially in lung disease 7
- Normal gradient: PaCO₂ - PETCO₂ = 2-7 mmHg at rest 8
- PETCO₂ may exceed PaCO₂ during exercise in normal individuals 7
- Inaccurate with mouth breathing, low tidal volumes, supplemental oxygen, or mask ventilation 8
Transcutaneous CO₂ (PTCCO₂):
- May be useful when calibrated and validated against arterial samples (within 10 mmHg agreement) 6
- Significant lag time (~2 minutes) behind actual PaCO₂ changes 8
- Preferred over PETCO₂ in lung disease, mouth breathing, or during supplemental oxygen/NIV 8
Critical Pitfalls
Do not use venous PCO₂ as an absolute representation of arterial PCO₂ 3. The wide limits of agreement (-20 to +26 mmHg) mean individual measurements can differ substantially, particularly in:
- Critically ill patients with circulatory compromise
- Patients with severe metabolic acidosis
- Elderly patients (even wider variability) 1
Capnography cannot reliably guide normoventilation in critically ill intubated patients—79% of patients had PaCO₂-EtCO₂ gradients exceeding 0.67 kPa (5 mmHg), with bias of 1.7 kPa and limits of agreement -1.4 to 4.8 kPa 9.
Practical Algorithm
- For screening/trending in stable patients: Venous PCO₂ acceptable if normal values exclude pathology
- For acute respiratory distress or critical illness: Arterial PCO₂ mandatory 4
- For ventilator management: Arterial PCO₂ is gold standard; surrogate measures require validation 6
- For sleep studies/chronic hypoventilation: Transcutaneous PCO₂ preferred over end-tidal 8